Article
Phenotypic drug profiling in droplet microfluidics for better targeting of drug-resistant tumors.
Lab on a chip - 7 Dec 2015
Sarkar S, Cohen N, Sabhachandani P, Konry T
Abstract excerpt
Acquired drug resistance is a key factor in the failure of chemotherapy. Due to intratumoral heterogeneity, cancer cells depict variations in intracellular drug uptake and efflux at the single cell level, which may not be detectable in bulk assays. In this study we present a droplet microfluidics-based approach to assess the dynamics of drug uptake, efflux and cytotoxicity in drug-sensitive and drug-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
